You have 9 free searches left this month | for more free features.

etoposide

Showing 51 - 75 of 942

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia Trial in Duarte (drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,

Not yet recruiting
  • Limited Stage Lung Small Cell Carcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Nov 10, 2023

Hemophagocytic Lymphohistiocytosis Trial in United States (Ruxolitinib, Dexamethasone, Etoposide)

Recruiting
  • Hemophagocytic Lymphohistiocytosis
  • Phoenix, Arizona
  • +9 more
Jan 9, 2023

Aggressive Non-Hodgkin Lymphoma Trial in Belgium, France (drug, other, procedure)

Recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • Brugge, Belgium
  • +21 more
Jan 9, 2023

SCLC Trial in Shanghai (Carboplatin, Cisplatin, Etoposide)

Active, not recruiting
  • SCLC
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Jul 18, 2022

Small Cell Lung Cancer, SCLC, Extensive Stage Small Cell Lung Cancer Trial (Durvalumab, Monalizumab, Carboplatin or Cisplatin)

Not yet recruiting
  • Small Cell Lung Cancer
  • +2 more
  • (no location specified)
Jun 5, 2023

Testicular Cancer Trial in Houston, Seattle (Gemcitabine, Docetaxel, Melphalan)

Active, not recruiting
  • Testicular Cancer
  • Houston, Texas
  • +1 more
Dec 5, 2022

Extensive-stage Small-cell Lung Cancer Trial in Shanghai (ZKAB001, Placebo, Carboplatin)

Recruiting
  • Extensive-stage Small-cell Lung Cancer
  • ZKAB001
  • +3 more
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Sep 8, 2021

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in United States (drug, other, biological)

Active, not recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Duarte, California
  • +3 more
Oct 24, 2022

Adult Acute Lymphocytic Leukemia Trial in Frankfurt (Cyclophosphamide, Dexamethasone, Vincristine)

Completed
  • Adult Acute Lymphocytic Leukemia
  • Frankfurt, Germany
    University of Frankfurt, Medical Dept. II
Aug 17, 2022

Richter Syndrome, Chronic Lymphocytic Leukemia Trial in New York (Polatuzumab Vedotin, Rituximab, Etoposide)

Recruiting
  • Richter Syndrome
  • Chronic Lymphocytic Leukemia
  • Polatuzumab Vedotin
  • +5 more
  • New York, New York
    Weill Cornell Medicine
Dec 19, 2022

Small Cell Lung Cancer Extensive Stage Trial in Spain (Lenvatinib, Pembrolizumab, Etoposide)

Recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Badalona, Barcelona, Spain
  • +17 more
Jan 26, 2023

Leukemia Trial (biological, drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • aldesleukin
  • +9 more
  • (no location specified)
Feb 17, 2022

High-risk Large B-cell Lymphoma (LBCL) Trial (Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine)

Not yet recruiting
  • High-risk Large B-cell Lymphoma (LBCL)
  • Axicabtagene Ciloleucel
  • +7 more
  • (no location specified)
Dec 13, 2022

Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston (drug,

Recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 8, 2022

Lung Cancer, Small-cell Lung Cancer, Non Small Cell Lung Cancer Trial in Philadelphia (Carboplatin, Pemetrexed, Paclitaxel)

Recruiting
  • Lung Cancer
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Mar 24, 2023

Small Cell Lung Cancer Trial in Worldwide (Venetoclax, Atezolizumab, Carboplatin)

Terminated
  • Small Cell Lung Cancer
  • Atlanta, Georgia
  • +4 more
Oct 8, 2021

Diffuse Large B-cell Lymphoma Trial (Rituximab, Mitoxantrone HCl liposome, Isophosphamide)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • (no location specified)
Mar 23, 2023

Mature B-Cell Non-Hodgkin Lymphoma Trial (Obinutuzumab, Glofitamab, Rituximab)

Not yet recruiting
  • Mature B-Cell Non-Hodgkin Lymphoma
  • (no location specified)
Sep 6, 2022

Neuroblastoma Trial in Minneapolis (Thiotepa, Cyclophosphamide, Melphalan)

Recruiting
  • Neuroblastoma
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 2, 2022

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Seattle (drug, other, biological)

Completed
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 18, 2022

Small Cell Lung Carcinoma Trial in Italy (Atezolizumab, Carboplatin, Etoposide)

Active, not recruiting
  • Small Cell Lung Carcinoma
  • Rionero In Vulture (PZ), Basilicata, Italy
  • +24 more
Dec 12, 2022

Lymphoma Trial (biological, drug, procedure, radiation)

Completed
  • Lymphoma
  • filgrastim
  • +4 more
  • (no location specified)
Jun 16, 2021

Ovarian Germ Cell Cancer, Ovarian Tumors, Ovarian Cancer Trial in Jinan (Paclitaxel, Carboplatin, Bleomycin)

Recruiting
  • Ovarian Germ Cell Cancer
  • +2 more
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
Oct 7, 2021

Ovarian Sex Cord Stromal Tumor, Ovarian Tumors, Ovarian Cancer Trial in Jinan (Paclitaxel, Carboplatin, Bleomycin)

Recruiting
  • Ovarian Sex Cord Stromal Tumor
  • +2 more
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
Oct 7, 2021